A timeline for Parkinson's disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works

Non-motor symptoms of Parkinson's disease: diagnosis and management

Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807 · see citing works

Stages in the development of Parkinson’s disease-related pathology

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845 · see citing works

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · see citing works

Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · see citing works

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder

Schenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083 · see citing works

Parkinson's disease: a dual‐hit hypothesis

Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021 · see citing works

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

Iranzo, Á., Molinuevo, J. L., Santamaría, J., Serradell, M., Martı́, M. J., Valldeoriola, F., & Tolosa, E. S. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70476-8 · Cited by 950 · see citing works

Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease

Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839 · see citing works

Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

Doty, R. L., Deems, D. A., & Stellar, S. (1988) · Neurology · doi:10.1212/wnl.38.8.1237 · Cited by 838 · see citing works

The pedunculopontine nucleus and Parkinson's disease

Pahapill, P. A. (2000) · Brain · doi:10.1093/brain/123.9.1767 · Cited by 832 · see citing works

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

Ponsen, M. M., Stoffers, D., Booij, J., van Eck‐Smit, B. L. F., Wolters, E. C., & Berendse, H. W. (2004) · Annals of Neurology · doi:10.1002/ana.20160 · Cited by 741 · see citing works

Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered

Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630 · see citing works

Invited Article: Nervous system pathology in sporadic Parkinson disease

Braak, H., & Tredici, K. D. (2008) · Neurology · doi:10.1212/01.wnl.0000312279.49272.9f · Cited by 536 · see citing works

Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2007) · Brain · doi:10.1093/brain/awm302 · Cited by 462 · see citing works

Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression

Klimek, V., Stockmeier, C. A., Overholser, J. C., Meltzer, H. Y., Kalka, S., Dilley, G. E., & Ordway, G. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08451.1997 · Cited by 445 · see citing works

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

Mendez, I. M., Viñuela, Á., Astradsson, A., Mukhida, K., Hallett, P. J., Robertson, H. A., Tierney, T. S., Holness, R. O., Dagher, A., Trojanowski, J. Q., et al. (2008) · Nature Medicine · doi:10.1038/nm1752 · Cited by 442 · see citing works

Excessive daytime sleepiness and subsequent development of Parkinson disease

Abbott, R. D., Ross, G. W., White, L. R., Tanner, C. M., Masaki, K., Nelson, J. S., Curb, J. D., & Petrovitch, H. (2005) · Neurology · doi:10.1212/01.wnl.0000183056.89590.0d · Cited by 439 · see citing works

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for -synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT

Stiasny‐Kolster, K. (2004) · Brain · doi:10.1093/brain/awh322 · Cited by 430 · see citing works

The progression of pathology in longitudinally followed patients with Parkinson’s disease

Halliday, G. M., Hely, M. A., Reid, W. G. J., & Morris, J. G. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0344-8 · Cited by 410 · see citing works

Locus coeruleus and regulation of behavioral flexibility and attention

(2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26013-5 · Cited by 400 · see citing works

Olfactory dysfunction in Parkinson's disease.

Hawkes, C. H., Shephard, B. C., & Daniel, S. E. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.5.436 · Cited by 399 · see citing works

A critical evaluation of the Braak staging scheme for Parkinson's disease

Burke, R. E., Dauer, W. T., & Vonsattel, J. P. (2008) · Annals of Neurology · doi:10.1002/ana.21541 · Cited by 377 · see citing works

Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation

Nolano, M., Provitera, V., Estraneo, A., Selim, M. M., Caporaso, G., Stancanelli, A., Saltalamacchia, A. M., Lanzillo, B., & Santoro, L. (2008) · Brain · doi:10.1093/brain/awn102 · Cited by 367 · see citing works

Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

Parkkinen, L., Pirttilä, T., & Alafuzoff, I. I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0346-6 · Cited by 357 · see citing works

Altered serotonin metabolism in depressed patients with Parkinson's disease

Mayeux, R. P., Stern, Y., COTE, L. J., & Williams, J. B. W. (1984) · Neurology · doi:10.1212/wnl.34.5.642 · Cited by 343 · see citing works

Higher incidence of depression preceding the onset of Parkinson's disease: A register study

Leentjens, A. F. G., van den Akker, M., Metsemakers, J. F. M., Lousberg, R. L., & Verhey, F. R. J. (2003) · Movement Disorders · doi:10.1002/mds.10387 · Cited by 339 · see citing works

Olfactory loss may be a first sign of idiopathic Parkinson's disease

Haehner, A., Hummel, T. R., Hummel, C., Sommer, U., Junghanns, S., & Reichmann, H. (2007) · Movement Disorders · doi:10.1002/mds.21413 · Cited by 333 · see citing works

α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia

Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. I. (2004) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 315 · see citing works

Pain in Parkinson's disease

Goetz, C. G., Tanner, C. M., Levy, M., Wilson, R. S., & Garron, D. C. (1986) · Movement Disorders · doi:10.1002/mds.870010106 · Cited by 314 · see citing works

Transplanted dopaminergic neurons develop PD pathologic changes: A second case report

Kordower, J. H., Chu, Y., Hauser, R. A., Olanow, C. W., & Freeman, T. B. (2008) · Movement Disorders · doi:10.1002/mds.22369 · Cited by 286 · see citing works

Patient-reported autonomic symptoms in Parkinson disease

Verbaan, D., Marinus, J., Jeukens‐Visser, M., van Rooden, S. M., Stiggelbout, A. M., & van Hilten, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000266593.50534.e8 · Cited by 283 · see citing works

Cognitive dysfunction and dementia in Parkinson?s disease

Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0168-1 · Cited by 274 · see citing works

Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases

Iwanaga, K., Wakabayashi, K., Yoshimoto, M., Tomita, I., Satoh, H., Takashima, H., Satoh, A., Seto, M., Tsujihata, M., & Takahashi, H. (1999) · Neurology · doi:10.1212/wnl.52.6.1269 · Cited by 274 · see citing works

Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease

Orimo, S., Takahashi, A., Uchihara, T., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00032.x · Cited by 243 · see citing works

A critical reappraisal of current staging of Lewy-related pathology in human brain

Jellinger, K. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0406-y · Cited by 229 · see citing works

Pathological lesions in colonic biopsies during Parkinson’s disease

Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., Naveilhan, P., Galmiche, J.-P., Varannes, S. B. D., Derkinderen, P., et al. (2008) · Gut · doi:10.1136/gut.2008.162503 · Cited by 229 · see citing works

Gastrointestinal dysfunction in Parkinson's disease

Edwards, L., Quigley, E., & Pfeiffer, R. (1992) · Neurology · doi:10.1212/wnl.42.4.726 · Cited by 226 · see citing works

The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding

Sutcliffe, J. G., & de Lecea, L. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001015)62:2 · Cited by 217 · see citing works

Lewy Body Pathology Involves Cutaneous Nerves

Ikemura, M., Saito, Y., Sengoku, R., Sakiyama, Y., Hatsuta, H., Kanemaru, K., Sawabe, M., Arai, T., Ito, G., Iwatsubo, T., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318186de48 · Cited by 215 · see citing works

Symptoms and duration of the prodromal phase in parkinson's disease

Gonera, E. G., Hof, M. V., Berger, H. J. C., van Weel, C., & Horstink, M. W. I. M. (1997) · Movement Disorders · doi:10.1002/mds.870120607 · Cited by 212 · see citing works

Lewy Body Pathology in Normal Elderly Subjects

Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ac10a7 · Cited by 210 · see citing works

Body mass index and the risk of Parkinson disease

Hu, G., Jousilahti, P., Nissinen, A., Antikainen, R., Kivipelto, M., & Tuomilehto, J. (2006) · Neurology · doi:10.1212/01.wnl.0000247052.18422.e5 · Cited by 203 · see citing works

Bowel movement frequency in late‐life and incidental Lewy bodies

Abbott, R. D., Ross, G. W., Petrovitch, H., Tanner, C. M., Davis, D. G., Masaki, K., Launer, L. J., Curb, J. D., & White, L. R. (2007) · Movement Disorders · doi:10.1002/mds.21560 · Cited by 203 · see citing works

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

Ben‐Shlomo, Y., & Marmot, M. G. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.3.293 · Cited by 202 · see citing works

α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0725-y · Cited by 201 · see citing works

Association of olfactory dysfunction with incidental Lewy bodies

Ross, G. W., Abbott, R. D., Petrovitch, H., Tanner, C. M., Davis, D. G., Nelson, J. R., Markesbery, W. R., Hardman, J. M., Masaki, K., Launer, L. J., et al. (2006) · Movement Disorders · doi:10.1002/mds.21076 · Cited by 194 · see citing works

Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders?

Mínguez‐Castellanos, A., Chamorro, C. E., Sevilla, F. E., Ortega-Moreno, A., Rebollo, A. C., Gómez-Río, M., Concha, A., & Muñoz, D. G. (2007) · Neurology · doi:10.1212/01.wnl.0000264429.59379.d9 · Cited by 183 · see citing works

Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study

Nilsson, F. M., Kessing, L. V., & Bolwig, T. G. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00372.x · Cited by 180 · see citing works

Survival Study of Parkinson Disease in Olmsted County, Minnesota

Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179 · see citing works

Levodopa unresponsive symptoms in Parkinson disease

Sethi, K. D. (2008) · Movement Disorders · doi:10.1002/mds.22049 · Cited by 177 · see citing works

Manifestations of Parkinson disease differ in association with REM sleep behavior disorder

Postuma, R. B., Gagnon, J., Vendette, M., Charland, K., & Montplaisir, J. Y. (2008) · Movement Disorders · doi:10.1002/mds.22099 · Cited by 173 · see citing works

Brain structures and receptors involved in alertness

Aston‐Jones, G. (2005) · Sleep Medicine · doi:10.1016/s1389-9457(05)80002-4 · Cited by 168 · see citing works

The premotor phase of Parkinson's disease

TOLOSA, E. S., Compta, Y., & Gaig, C. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.06.007 · Cited by 165 · see citing works

Midlife adiposity and the future risk of Parkinson’s disease

Abbott, R. D., Ross, G. W., White, L. R., Nelson, J. S., Masaki, K., Tanner, C. M., Curb, J. D., Blanchette, P. L., Popper, J. S., & Petrovitch, H. (2002) · Neurology · doi:10.1212/wnl.59.7.1051 · Cited by 163 · see citing works

Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease

Fujishiro, H., Frigerio, R., Burnett, M. S., Klos, K. J., Josephs, K. A., DelleDonne, A., Parisi, J. E., Ahlskog, J. E., & Dickson, D. W. (2008) · Movement Disorders · doi:10.1002/mds.21989 · Cited by 163 · see citing works

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease

Kalaitzakis, M. E., Christian, L., Moran, L. B., Graeber, M. B., Pearce, R. K. B., & Gentleman, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.007 · Cited by 146 · see citing works

The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?

Hawkes, C. H. (2008) · Movement Disorders · doi:10.1002/mds.22242 · Cited by 144 · see citing works

The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis

Fibiger, H. C. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046230 · Cited by 143 · see citing works

Parkinson Disease Survival

Morgante, L., Salemi, G., Meneghini, F., Rosa, A. E. D., Epifanio, A., Grigoletto, F., Ragonese, P., Patti, F., Reggio, A., Perri, R. D., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.4.507 · Cited by 143 · see citing works

Long–term survival of Parkinson's disease: A population–based study

D'Amelio, M., Ragonese, P., Morgante, L., Reggio, A., Callari, G., Salemi, G., & Savettieri, G. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0916-7 · Cited by 121 · see citing works

Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology

Rüb, U., Tredici, K. D., Schultz, C., Ghebremedhin, E., de Vos, R. A. I., Steur, E. N. H. J., & Braak, H. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00269-x · Cited by 121 · see citing works

Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered

Braak, H., & Tredici, K. D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.001 · Cited by 120 · see citing works

Obesity and the Risk of Parkinson's Disease

Chen, H. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh059 · Cited by 118 · see citing works

Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease

Halliday, G. M., Tredici, K. D., & Braak, H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_16 · Cited by 113 · see citing works

Erectile Function and Risk of Parkinson's Disease

Gao, X., Chen, H., Schwarzschild, M. A., Glasser, D. B., Logroscino, G., Rimm, E. B., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm246 · Cited by 112 · see citing works

Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease

Haensch, C., Lerch, H., Jörg, J., & Isenmann, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.031 · Cited by 107 · see citing works

Dose–response effects of orexin-A on food intake and the behavioural satiety sequence in rats

Rodgers, R. J., Halford, J. C. G., de Souza, R. L. N., de Souza, A. L. C., Piper, D. C., Arch, J. R. S., & Blundell, J. E. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00203-2 · Cited by 107 · see citing works

Abnormality of taste and smell in Parkinson's disease

Shah, M., Deeb, J., Fernando, M., Noyce, A. J., Visentin, E., Findley, L. J. J., & Hawkes, C. H. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.008 · Cited by 99 · see citing works

Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability

Müller, C. M., de Vos, R. A. I., Maurage, C., Thal, D. R., Tolnay, M., & Braak, H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171652.40083.15 · Cited by 94 · see citing works

Use of antidepressants and the risk of Parkinson's disease: a prospective study

Alonso, Á., Rodríguez, L. A. G., Logroscino, G., & Hernán, M. Á. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.152983 · Cited by 91 · see citing works

Drug addiction: Functional neurotoxicity of the brain reward systems

Weiss, F., & Koob, G. F. (2001) · Neurotoxicity Research · doi:10.1007/bf03033235 · Cited by 86 · see citing works

Mortality and Parkinson disease

Herlofson, K., Lie, S. A., Årsland, D., & Larsen, J. O. (2004) · Neurology · doi:10.1212/01.wnl.0000115116.56955.50 · Cited by 82 · see citing works

Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease

Shibata, M., Morita, Y., Shimizu, T., Takahashi, K., & Suzuki, N. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.09.005 · Cited by 81 · see citing works

Regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation

Thorpe, A. J., Mullett, M. A., Wang, C., & Kotz, C. M. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00344.2002 · Cited by 77 · see citing works

Control of sleep and wakefulness by brainstem monoaminergic and cholinergic neurons

Kayama, Y., & Koyama, Y. (2003) · Springer eBooks · doi:10.1007/978-3-7091-6081-7_1 · Cited by 75 · see citing works

Body Mass Index and Risk of Parkinson's Disease: A Prospective Cohort Study

Logroscino, G., Sesso, H. D., Paffenbarger, R. S., & Lee, I.-M. M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm211 · Cited by 69 · see citing works

A not entirely benign procedure: progression of Parkinson’s disease

Tredici, K. D., & Braak, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0355-5 · Cited by 67 · see citing works

Hyposmia in G2019S LRRK2-related parkinsonism

Silveira‐Moriyama, L., Guedes, L. C., Kingsbury, A. E., Ayling, H., Shaw, K., Barbosa, E. R., Bonifati, V., Quinn, N. P., Abou‐Sleiman, P. M., Wood, N. W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000326575.20829.45 · Cited by 65 · see citing works

New insights into the pathology of Parkinson’s disease: does the peripheral autonomic system become central?

Probst, A., Bloch, A., & Tolnay, M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02057.x · Cited by 58 · see citing works

Pain in Parkinson's disease: Common yet seldom recognized symptom is treatable

Waseem, S., & Gwinn-Hardy, K. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.12.1063 · Cited by 54 · see citing works

Prospective association between emotional health and clinical evidence of Parkinson’s disease

Ishihara-Paul, L., Wainwright, N. W. J., Khaw, K., Luben, R., Welch, A. A., Day, N., Brayne, C., & Surtees, P. G. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02299.x · Cited by 51 · see citing works

Acquired colour deficiency in patients with Parkinson’s disease

Birch, J., Kolle, R., Kunkel, M., Paulus, W., & Upadhyay, P. (1998) · Vision Research · doi:10.1016/s0042-6989(97)00398-2 · Cited by 49 · see citing works

Early Diagnosis and Preventive Therapy in Parkinson’s Disease

Przuntek, H., & Riederer, P. F. (1989) · Key topics in brain research · doi:10.1007/978-3-7091-8994-8 · Cited by 46 · see citing works

Parkinson's disease and aging: Same or different process?

Hawkes, C. H. (2007) · Movement Disorders · doi:10.1002/mds.21766 · Cited by 46 · see citing works

The morphological basis of mental dysfunction in Parkinson's disease

Jellinger, K. A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.002 · Cited by 44 · see citing works

Progress of visual dysfunction in Parkinson's disease

Müller, T., Woitalla, D., Peters, S. A., Kohla, K., & Przuntek, H. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.1o154.x · Cited by 39 · see citing works

Pain in Parkinson disease

Búzás, B., & Max, M. B. (2004) · Neurology · doi:10.1212/01.wnl.0000130384.56476.75 · Cited by 36 · see citing works

Spontaneous and artificial lesions of magnocellular reticular formation of brainstem deteriorate avoidance learning in senescence-accelerated mouse SAM

Yagi, H., Akiguchi, I., Ohta, A., et al. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00070-5 · Cited by 24 · see citing works

Heterotypic sexual behavior in male rats after lesions in different amygdaloid nuclei.

Chateau, D., & Aron, C. (1988) · Hormones and Behavior · doi:10.1016/0018-506x(88)90009-8 · Cited by 21 · see citing works

Behavioral memory induced by stimulation of the nucleus basalis: Effects of contingency reversal

Miasnikov, A. A., Chen, J. C., & Weinberger, N. M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.12.010 · Cited by 14 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

Maternal immune activation and abnormal brain development across CNS disorders

Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880 · see citing works

Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study

Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674 · see citing works

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works

Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease

Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · see citing works

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease

Gelders, G., Baekelandt, V., & Van der Perren, A. (2018) · Journal of Immunology Research · doi:10.1155/2018/4784268 · Cited by 430 · see citing works

Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice

Challis, C., Hori, A., Sampson, T. R., Yoo, B. B., Challis, R. C., Hamilton, A. M., Mazmanian, S. K., Volpicelli-Daley, L. A., & Gradinaru, V. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0589-7 · Cited by 405 · see citing works

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405 · see citing works

Gut microbiota in Parkinson disease in a northern German cohort

Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318 · see citing works

Vagal neurocircuitry and its influence on gastric motility

Travagli, R. A., & Anselmi, L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.76 · Cited by 323 · see citing works

Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases

Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298 · see citing works

Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study

Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187307 · Cited by 248 · see citing works

α-Synuclein in gut endocrine cells and its implications for Parkinson’s disease

Chandra, R., Hiniker, A., Kuo, Y.-M., Nussbaum, R. L., & Liddle, R. A. (2017) · JCI Insight · doi:10.1172/jci.insight.92295 · Cited by 236 · see citing works

The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies

Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203 · see citing works

Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms

Váradi, C. (2020) · Biology · doi:10.3390/biology9050103 · Cited by 196 · see citing works

Neuron-Astrocyte Interactions in Parkinson’s Disease

Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186 · see citing works

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson’s Disease

Dijkstra, A. A., Ingrassia, A., de Menezes, R. X., van Kesteren, R. E., Rozemuller, A. J. M., Heutink, P., & van de Berg, W. D. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128651 · Cited by 167 · see citing works

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease

Yang, D., Zhao, D., Ali Shah, S. Z., Wu, W., Lai, M., Zhang, X., Li, J., Guan, Z., Zhao, H., Li, W., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01155 · Cited by 162 · see citing works

Gut-brain and brain-gut axis in Parkinson’s disease models: effects of a uridine and fish oil diet

Perez-Pardo, P., Dodiya, H. B., Broersen, L. M., Douna, H., van Wijk, N., Lopes da Silva, S., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1294555 · Cited by 111 · see citing works

A prospective study of bowel movement frequency and risk of Parkinson's disease

Gao, X., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr119 · Cited by 115 · see citing works

Gut bacterial composition in a mouse model of Parkinson’s disease

Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0202 · Cited by 102 · see citing works

Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease

Stuebner, E., Vichayanrat, E., Low, D. A., Mathias, C. J., Isenmann, S., & Haensch, C.-A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00049 · Cited by 84 · see citing works

Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications

Chen, H., Burton, E. A., Ross, G. W., Huang, X., Savica, R., Abbott, R. D., Ascherio, A., Caviness, J. N., Gao, X., Gray, K. A., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306967 · Cited by 83 · see citing works

Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse

Smith, B. A., Goldberg, N. R. S., & Meshul, C. K. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.003 · Cited by 67 · see citing works

Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat

Anselmi, L., Bove, C., Coleman, F. H., Le, K., Subramanian, M. P., Venkiteswaran, K., Subramanian, T., & Travagli, R. A. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0066-0 · Cited by 63 · see citing works

Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice

Miyazaki, I., Isooka, N., Wada, K., Kikuoka, R., Kitamura, Y., & Asanuma, M. (2019) · Cells · doi:10.3390/cells8030221 · Cited by 53 · see citing works

Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain

Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13 · see citing works

Non-Motor Fluctuations in Parkinson's Disease (PD): Development and Validation of the Non-Motor Fluctuation Assessment Instrument (NoMoFA)

Margolius, A. J., Kleiner, G., Fernandez, H. H., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.06.165

Predictors of quality of life in Parkinson's Disease

Luengos, I. S., Lucas‐Jiménez, O., Peña, J., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.06.091

Relationship between motor subtype and cognitive function in untreated, early-stage Parkinson's disease

Terashi, H., Taguchi, T., Ueta, Y., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.2932

Study of an integrated non-motor symptoms questionnaire for Parkinson＇s disease

Yū, Bo, B., Xiao, et al. (2010) · 中华医学杂志：英文版

1.126 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): Results form the international PD non-motor symptoms scale study

Naidu, Y., Contrafatto, D., Martínez‐Martín, P., et al. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70397-3